Action potential characterization of human induced pluripotent stem cell-derived cardiomyocytes using automated patch-clamp technology

Assay and Drug Development Technologies

Volumn 12, Issue 8, 2014, Pages 457-469

  Scheel, Olaf ^a   Frech, Stefanie ^a   Amuzescu, Bogdan ^a   Eisfeld, Jörg ^a   Lin, Kun Han ^a,b   Knott, Thomas ^a  

^a Cytocentrics Bioscience GmbH   (Germany)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; NIFEDIPINE; TETRODOTOXIN; CALCIUM CHANNEL BLOCKING AGENT; LOCAL ANESTHETIC AGENT; SEROTONIN AGONIST;

ARTICLE; AUTOMATED PATCH CLAMP; CONTROLLED STUDY; CURRENT CLAMP TECHNIQUE; DRUG EFFECT; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART PACING; HUMAN; HUMAN CELL; MEMBRANE RESISTANCE; PHENOTYPE; PLURIPOTENT STEM CELL; QUANTITATIVE ANALYSIS; RECORDER; VOLTAGE CLAMP TECHNIQUE; WHOLE CELL PATCH CLAMP; ACTION POTENTIAL; AUTOMATION; CELL CULTURE; DRUG EFFECTS; PATCH CLAMP TECHNIQUE; PROCEDURES; REPRODUCIBILITY;

ACTION POTENTIALS; ANESTHETICS, LOCAL; AUTOMATION; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; CISAPRIDE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCYTES, CARDIAC; NIFEDIPINE; PATCH-CLAMP TECHNIQUES; REPRODUCIBILITY OF RESULTS; SEROTONIN RECEPTOR AGONISTS; TETRODOTOXIN;

EID: 84909981167     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2014.601     Document Type: Article

References (60)

1. Noble D: A modification of the Hodgkin-Huxley equations applicable to Purkinje fibre action and pace-maker potentials. J Physiol 1962;160:317-352
2. Noble D: Modeling the heart. Physiology (Bethesda) 2004;19:191-197
3. Draper MH, Weidmann S: Cardiac resting and action potentials recorded with an intracellular electrode. J Physiol 1951;115:74-94
4. Hutter OF, Noble D: Rectifying properties of heart muscle. Nature 1960; 188:495
5. Clark RB, Giles WR, Imaizumi Y: Properties of the transient outward current in rabbit atrial cells. J Physiol 1988;405:147-168
6. Josephson IR, Sanchez-Chapula J, Brown AM: Early outward current in rat single ventricular cells. Circ Res 1984;54:157-162
7. Litovsky SH, Antzelevitch C: Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ Res 1988;62:116-126
8. Nakayama T, Fozzard HA: Adrenergic modulation of the transient outward current in isolated canine Purkinje cells. Circ Res 1988;62:162-172
9. Sipido KR, Callewaert G, Carmeliet E: [Ca2 + ]i transients and [Ca2 + ]idependent chloride current in single Purkinje cells from rabbit heart. J Physiol 1993;468:641-667
10. Zygmunt AC, Gibbons WR: Calcium-activated chloride current in rabbit ventricular myocytes. Circ Res 1991;68:424-437
11. DiFrancesco D: A new interpretation of the pace-maker current in calf Purkinje fibres. J Physiol 1981;314:359-376
12. Deck KA, Trautwein W: Ionic currents in cardiac excitation. Pflügers Arch Gesamte Physiol Menschen Tiere 1964;280:63-80
13. Reuter H: The dependence of slow inward current in Purkinje fibres on the extracellular calcium-concentration. J Physiol 1967;192:479-492
14. Thomas D, Karle CA, Kiehn J: The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications. Curr Pharm Des 2006;12:2271-2283
15. Sato D, Xie LH, Sovari AA, et al.: Synchronization of chaotic early after depolarizations in the genesis of cardiac arrhythmias. Proc Natl Acad Sci U S A 2009;106:2983-2988
16. Noble D: Computational models of the heart and their use in assessing the actions of drugs. J Pharmacol Sci 2008;107:107-117
17. Kramer J, Obejero-Paz CA, Myatt G, et al.: MICE models: superior to the HERG model in predicting Torsade de Pointes. Sci Rep 2013;3:2100
18. Sager PT, Gintant G, Turner JR, Pettit S, Stockbridge N: Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the cardiac safety research consortium. Am Heart J 2014;167:292-300
19. O'Hara T, Virag L, Varro A, Rudy Y: Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation. PLoS Comput Biol 2011;7:e1002061
20. Thorrez L, Sampaolesi M: The future of induced pluripotent stem cells for cardiac therapy and drug development. Curr Pharm Des 2011;17:3258-3270
21. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126: 663-676
22. Ma J, Guo L, Fiene SJ, et al.: High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am J Physiol Heart Circ Physiol 2011;301: H2006-H2017
23. Burridge PW, Thompson S, Millrod MA, et al.: A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One 2011;6:e18293
24. Mehta A, Chung Y, Sequiera GL, Wong P, Liew R, Shim W: Pharmacoelectrophysiology of viral-free induced pluripotent stem cell-derived human cardiomyocytes. Toxicol Sci 2013;131:458-469
25. Himmel HM: Drug-induced functional cardiotoxicity screening in stem cellderived human and mouse cardiomyocytes: effects of reference compounds. J Pharmacol Toxicol Methods 2013;68:97-111
26. Stett A, Burkhardt C, Weber U, van Stiphout P, Knott T: CYTOCENTERING: a novel technique enabling automated cell-by-cell patch clamping with the CYTOPATCH chip. Receptors Channels 2003;9:59-66
27. Colquhoun D, Sigworth FJ: Fitting and Statistical Analysis of Single-Channel Records. In: Single-Channel Recording, second edition. Sakmann B, Neher E, (eds.), pp. 483-588. Plenum Press, New York and London, 1995
28. Davis RP, Casini S, Van Den Berg CW, et al.: Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation 2012;125: 3079-3091
29. Ivashchenko CY, Pipes GC, Lozinskaya IM, et al.: Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype. Am J Physiol Heart Circ Physiol 2013;305:H913-H922
30. Sheng X, Reppel M, Nguemo F, et al.: Human pluripotent stem cell-derived cardiomyocytes: response to TTX and lidocain reveals strong cell to cell variability. PLoS One 2012;7:e45963
31. He JQ, Ma Y, Lee Y, Thomson JA, Kamp TJ: Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003;93:32-39
32. Zhang J, Wilson GF, Soerens AG, et al.: Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009;104:e30-e41
33. Zhang Q, Jiang J, Han P, et al.: Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell Res 2011;21:579-587
34. Itzhaki I, Maizels L, Huber I, et al.: Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011;471:225-229
35. Lahti AL, Kujala VJ, Chapman H, et al.: Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Dis Model Mech 2012;5:220-230
36. Moretti A, Bellin M, Welling A, et al.: Patient-specific induced pluripotent stemcell models for long-QT syndrome. N Engl J Med 2010;363:1397-1409
37. Birket MJ, Casini S, Kosmidis G, et al.: PGC-1alpha and reactive oxygen species regulate human embryonic stem cell-derived cardiomyocyte function. Stem Cell Rep 2013;1:560-574
38. Hoekstra M, Mummery CL, Wilde AA, Bezzina CR, Verkerk AO: Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias. Front Physiol 2012;3:346
39. Josowitz R, Carvajal-Vergara X, Lemischka IR, Gelb BD: Induced pluripotent stem cell-derived cardiomyocytes as models for genetic cardiovascular disorders. Curr Opin Cardiol 2011;26:223-229
40. Knollmann BC: Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model?. Circ Res 2013;112:969-976; discussion 976
41. Current and Voltage Clamp Recordings of Human Patient-Specific iPS Cardiomyocytes. www.cytocentrics.com/de-de/newsmedia/downloadinformation.aspx
42. Amuzescu B, Georgescu A, Nistor G, et al.: Stability and sustained oscillations in a ventricular cardiomyocyte model. Interdiscip Sci 2012;4:1-18
43. Chay TR, Lee YS: Phase resetting and bifurcation in the ventricular myocardium. Biophys J 1985;47:641-651
44. Gibb WJ, Wagner MB, Lesh MD: Effects of simulated potassium blockade on the dynamics of triggered cardiac activity. J Theor Biol 1994;168:245-257
45. Kurata Y, Hisatome I, Imanishi S, Shibamoto T: Roles of L-type Ca2 + and delayed-rectifier K + currents in sinoatrial node pacemaking: insights from stability and bifurcation analyses of a mathematical model. Am J Physiol Heart Circ Physiol 2003;285:H2804-H2819
46. Kurata Y, Matsuda H, Hisatome I, Shibamoto T: Regional difference in dynamical property of sinoatrial node pacemaking: role of Na + channel current. Biophys J 2008;95:951-977
47. Vinet A, Roberge FA: A model study of stability and oscillations in the myocardial cell membrane. J Theor Biol 1990;147:377-412
48. Bodewei R, Hering S, Lemke B, Rosenshtraukh LV, Undrovinas AI, Wollenberger A: Characterization of the fast sodium current in isolated rat myocardial cells: simulation of the clamped membrane potential. J Physiol 1982;325:301-315
49. Brown AM, Lee KS, Powell T: Sodium current in single rat heart muscle cells. J Physiol 1981;318:479-500
50. Zilberter YI, Timin EN, Bendukidze ZA, Burnashev NA: Patch-voltage-clamp method for measuring fast inward current in single rat heart muscle cells. Pflugers Arch 1982;394:150-155
51. Luo CH, Rudy Y: A model of the ventricular cardiac action potential. Depolarization, repolarization, and their interaction. Circ Res 1991;68:1501-1526
52. Aggarwal R, Shorofsky SR, Goldman L, Balke CW: Tetrodotoxin-blockable calcium currents in rat ventricular myocytes; a third type of cardiac cell sodium current. J Physiol 1997;505 (Pt 2):353-369
53. Bers DM: Cardiac excitation-contraction coupling. Nature 2002;415:198-205
54. Faber GM, Silva J, Livshitz L, Rudy Y: Kinetic properties of the cardiac L-type Ca2 + channel and its role in myocyte electrophysiology: a theoretical investigation. Biophys J 2007;92:1522-1543
55. Wang X, Gao G, Guo K, et al.: Phospholemman modulates the gating of cardiac L-type calcium channels. Biophys J 2010;98:1149-1159
56. Townsend C: Is there a need to add another dimension (time) to the evaluation of the arrhythmogenic potential of new drug candidates in vitro?. Circulation 2014;130:219-220
57. Grandi E, Puglisi JL, Wagner S, Maier LS, Severi S, Bers DM: Simulation of Ca-calmodulin-dependent protein kinase II on rabbit ventricular myocyte ion currents and action potentials. Biophys J 2007;93:3835-3847
58. Mahajan A, Shiferaw Y, Sato D, et al.: A rabbit ventricular action potential model replicating cardiac dynamics at rapid heart rates. Biophys J 2008;94: 392-410
59. Scheel O, Himmel H, Rascher-Eggstein G, Knott T: Introduction of a modular automated voltage-clamp platform and its correlation with manual human ether-à-go-go related gene voltage-clamp data. Assay Drug Dev Technol 2011;9:600-607
60. Van de Waart B, Westerink W, Piñeiro N: An automated approach to solving Pharma's cardiac toxicity conundrum. Drug Discovery World Spring 2013; 2013